»ÆÉ«Ö±²¥

Genome Canada has launched a new funding opportunity for the generation of population-level genomic data, which will be the first pillar of its soon-to-be-announced large-scale precision health initiative. The goal of Genome Canada’s planned investment in the first pillar of the initiative is to sequence the genomes of at least 100,000 Canadians, reflecting Canada’s unique and diverse population. This will provide the rich dataset needed to advance research, drive innovation and improve health care outcomes for all Canadians.

To be eligible, projects must:

• Generate a minimum of 2,000 genomes.
• Complete whole-genome sequencing (WGS) at a Genome Canada–approved sequencing centre.
• Include self-identified race, ethnicity and ancestry data in their depositions and report and quantitatively characterize this data.
• Obtain Research Ethics Board approval.
• Obtain required participant consent.

Key Details:

• Funding Envelope: Approximately $60M for short-read WGS and $15M for long-read WGS.
• Project Duration: Up to 4 years, concluding by March 31, 2029.
• Funding Amounts: Up to $6M for short-read projects and up to $10M for long-read projects.
• Co-funding: Genome BC offers co-funding support for BC-based projects, matching up to 66.66% of Genome Canada’s contribution. ()Ìý

Please contact Elspeth White (elspeth.white@dal.ca) for further information.

The ORS internal deadline for this letter of intent is Wednesday, October 23.

The submission deadline for the Letter of Intent is 1:00 pm ADT, October 28, 2024.